Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase

Fig. 2

Effects of HJNO and MMC on the DNA binding of BLM642–1290 helicase. a Effects of HJNO on fluorescence anisotrophy of dsDNA or ssDNA (21 nt) and complexes of BLM642–1290 binding dsDNA or ssDNA (21 nt). b Effects of HJNO on the dsDNA or ssDNA (21 nt) binding of BLM642–1290 helicase. c Effects of MMC on fluorescence anisotrophy of dsDNA or ssDNA (21 nt) and complexes of BLM 642–1290 binding dsDNA or ssDNA (21 nt). d Effects of MMC on the dsDNA or ssDNA (21 nt) binding of BLM 642–1290 helicase. e, f Effects of HJNO on complexes of BLM642–1290 binding dsDNA detected by EMSA and statistic results. g, h Effects of MMC on complexes of BLM 642–1290 binding dsDNA detected by EMSA and statistic results. Note: A0 is the fluorescence anisotrophy of DNA binding small molecular substances. A1 is the fluorescence anisotrophy of complexes which is formed by BLM binding DNA and small molecules

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us